

Publisher: Bentham Science Publishers
E-ISSN: 1873-4316|12|2|243-253
ISSN: 1389-2010
Source: Current Pharmaceutical Biotechnology, Vol.12, Iss.2, 2011-02, pp. : 243-253
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Targeting DAX-1 in embryonic stem cells and cancer
Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. :








Cells Tissues Organs, Vol. 165, Iss. 3-4, 1999-12 ,pp. :